Founder and Medical Director of the London Vision Clinic (now part of the EuroEyes Group since 2022)
Professor Dan Reinstein is a globally recognised pioneer in therapeutic refractive surgery and a leader in advancing vision correction technologies. As a board-certified ophthalmic surgeon in the United Kingdom, the United States, and Canada, his expertise spans three continents, with appointments that reflect his profound influence in the field. Professor Reinstein is not only the founder and Medical Director of the renowned London Vision Clinic but also holds prestigious professorships at institutions like Columbia University in New York, Sorbonne University in Paris, and in the UK, where his teachings continue to shape the next generation of ophthalmic surgeons.
Presbyopia Treatment
One of Professor Reinstein’s hallmark contributions to refractive surgery is his invention of the Laser Blended Vision procedure, commercially known as PRESBYOND®. This innovative technique has transformed presbyopia treatment by providing patients with enhanced reading vision without compromising distance vision, making it a popular choice for individuals seeking freedom from reading glasses. As an editor for the Journal of Refractive Surgery’s Therapeutic Refractive Surgery section, Professor Reinstein is actively involved in setting research standards and evaluating groundbreaking advancements in the field, ensuring that the most effective and safe procedures are available to patients worldwide.
Professor Reinstein’s work has set a new standard in precision and personalisation in vision correction. His extensive research into the use of high-frequency ultrasound to map corneal tissue has been foundational in the field, enabling highly tailored surgical outcomes for patients with complex refractive needs. Under his leadership, the London Vision Clinic has become a top destination for advanced vision correction procedures, and its integration into the EuroEyes Group has expanded its reach and resources, allowing patients across Europe and beyond to benefit from the latest innovations in eye care.
